Myricetin ameliorates IDD by downregulating MMP-13 and ADAMTS and upregulating aggrecan and collagen II through the Nrf2/HO-1/NF-κB signalling pathway (Mao and Fan, 2024). This evidence concerns the gene NFKB1 and intervertebral disk degenerative disorder.